CVRx to Report First Quarter 2026 Financial Results and Host Conference Call
CVRx, Inc. will release its financial and operating results for Q1 2026 on May 11, 2026, and will host a conference call at 4:30 PM ET. The company focuses on neuromodulation solutions for cardiovascular diseases, with its Barostim device being a significant breakthrough in heart failure treatment.
MINNEAPOLIS, April 27, 2026 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release first quarter 2026 financial and operating results after market close on Monday, May 11, 2026. The Company will host a conference call to review its results at 4:30 p.m. Eastern Time the same day.